NCT01418430View on ClinicalTrials.gov

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
Interventions
DRUG

CHOP-daclizumab

Trial Locations (1)

SE5 9RS

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER

NCT01418430 - Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) | Biotech Hunter | Biotech Hunter